eujobs.coEU jobs in brussels
Post a JobHeadhunter

Global Antimicrobial Resistance Research and Development Hub

Acronym: Global AMR R&D Hub

General Information

Identification Code: 195253249430-67
Website: [object Object]
Entity Form: We are a temporary set up administered under the German Centre for Infection Research
Registration Category: Other organisations, public or mixed entities
Registration Date: 3/24/2023
Last Update: 3/11/2024
EP Accredited Number: 0

Mission & Interests

Goals: The Global AMR R&D Hub was launched in May 2018, following a call from G20 Leaders, to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach. The Global AMR R&D Hub supports global priority setting and evidence-based decision-making on allocation of resources for AMR R&D through the identification of gaps, overlaps and potential for cross-sectoral collaboration. It is a global partnership currently consisting of 17 countries, the European Commission (EC) and two philanthropic foundations - the Bill and Melinda Gates Foundation and the Wellcome Trust. Our work is steered by a Board of Members, in consultation with a Stakeholder Group, and supported by a Secretariat based in Berlin. The Hub's key activities include continual development of its Dynamic Dashboard, a key information platform for AMR R&D funding across the One Health spectrum, as well as AMR advocacy and communication efforts at the highest political levels.
Interests Represented: Does not represent commercial interests
Interests:
  • Environment
  • Food safety
  • Public health
  • Research and innovation
Levels of Interest:
  • global

Activities

Main EU Legislative Proposals: The Global AMR R&D Hub targets the following EU legislative proposals and policies: 1. A European One Health Action Plan against Antimicrobial Resistance (AMR): https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52017DC0339&qid=1678797696775; https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?reference=2017/2254(INI)&l=en 2. Pharmaceutical Strategy for Europe: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52020DC0761; https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?reference=2021/2013(INI)&l=en: Commission roadmaps and public consultations: Contribution to the 'Request for support to PwC for a study on medical countermeasures relevant to combat antimicrobial resistance', including the 'Questionnaire for Product Development Partnerships' Contribution to the Online Consultation: Research and Innovation Objectives for the OH AMR Partnership: https://www.jpiamr.eu/open-consultation-oh-amr-research-and-innovation-objectives/
Communication Activities: Communication activities to raise awareness of AMR and the challenges faced is a major component of the Global AMR R&D Hub's work. Although our communication activities do not focus solely on the legislative proposals/policies indicated above, the Hub's work encompasses the broader themes and issues covered in these policies, including research and development of products for addressing AMR and the optimisation of market incentives to encourage their sustainable market entry of and equitable access to these necessary new priority products. Examples activities include: Events: • Participation in multiple events on AMR R&D and pull incentives as part of the French Presidency of the Council of the European Union, March & June 2022; Participation in G20 Health Working Group meetings 2023 & 2024 Networks: • Founding member of the German Network Against AMR (DNAMR) - https://dnamr.de/ Publications - see https://globalamrhub.org/publications/: 1. Incentivising the development of new antibacterial treatments: Progress report by the Global AMR R&D Hub and WHO 2022 & 2023 2. National Health System Tools to improve valuation 3. Market potential and priority patient needs 4. Policy Makers Perspectives on Incentives 5. Public Investments in AMR R&D for animal health vaccines 6. Dynamic Dashboard Annual Report 2020 & 2021 Other activities: 1. AMR Snapshots: The Global AMR Hub's Interview series, which explores key challenges we are facing in AMR, exploring the topic from a variety of different perspectives and featuring key leaders in the field. https://globalamrhub.org/news/?filter=amr-snapshots
EU Supported Forums and Platforms: Antimicrobial Resistance One Health Network#E03853#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3853 #MEMBER #C#Other
Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: Schlüterstr. 39
Post Code: 10781
City: Berlin
Country: GERMANY
Phone: [object Object]

EU Office

Address: Schlüterstr. 39
Post Code: 10781
City: Berlin
Country: GERMANY
Phone: [object Object]

Financial Data

New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]

Membership Information

Members10 Percent: 3
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 3
Members F T E: 0.30000001192092896

Structure

Structure Type: Structure
Is Member Of: The Global AMR R&D Hub is a partnership of countries, non-governmental donor organisations and intergovernmental organisations to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach. It's Board Members include 17 countries (see list below), the European Commission (EC) and two philanthropic foundations - the Bill and Melinda Gates Foundation and the Wellcome Trust. WHO, FAO, WOAH, OECD and Africa CDC are Observers of the Board. A Secretariat operates under the umbrella of DZIF, the German Centre for Infection Research, and is funded by the German Ministry of Research and Education (BMBF). Members: Australia* Bill & Melinda Gates Foundation Canada* China* European Commission (EC)* France* Germany* India* Italy* Japan* The Netherlands Norway Russia* Spain Sweden Switzerland Turkey* United Kingdom* United States of America* Wellcome * G20 members
Organisation Members: German Network against Antimicrobial Resistance - https://dnamr.de/